ARCHIVES

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles.

September 7, 2001

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997